22. GM-2505 has Rapid Onset Antidepressant Activity and Causes Dose-Dependent Changes in qEEG With Increasing 5-HT2A Receptor Occupancy
Year: 2023
Type: article
Source: Biological Psychiatry
Authors: Zoe Hughes, Adam Klein, Dino Dvorak, Eric Austin, Laszlo Kiss, Gerard Marek, Jonathan Sporn, Andrew Kruegel
Institution: Gilgamesh Pharma (United States)
Language: English
Subfield: Clinical Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W4363648492
